학술논문

Examination of TIMP-1 Levels and Relapse-Free Survival for Patients in NCIC CTG MA.14 Who Received Adjuvant Tamoxifen+/- Octreotide LAR.
Document Type
Journal
Source
CANCER RESEARCH; DEC 15 2009, 69 24, p653S-p653S, 1p. Supplement: 3
Subject
Language
English
ISSN
00085472